Dr. Timothy Cote, Director of the Office of Orphan Product Development at the US FDA, presented at last year's World Orphan Drug Congress USA on the topic âBuilding an integrated, comprehensive and long-term strategy to address unmet patient needs in the US.'
Do you want to learn more about:
- Incentives to make orphan diseases a national priority
- Brownback/Brown Amendment status update
- Industry role in supporting product development
- Integrating industry, government and patient organization efforts
If so, you need to check out the video below: